Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection. - Wikidata - awgldk - TriplyDB

Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection.

Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection.

http://www.wikidata.org/entity/Q37684328

about

Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future Rare esophageal ulcers related to Behçet disease: A case report.

P2860

Q42730515-9FFC5EB0-50FF-456E-842B-A7694659D203 Q47100823-CF491959-74FC-4D31-84D3-247E2B696AD9

P2860

Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection.

http://www.wikidata.org/entity/Q37684328

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Characteristics of Macular Ede ...... vitreal Bevacizumab Injection.

@en

Characteristics of Macular Ede ...... vitreal Bevacizumab Injection.

@nl

type

label

Characteristics of Macular Ede ...... vitreal Bevacizumab Injection.

@en

Characteristics of Macular Ede ...... vitreal Bevacizumab Injection.

@nl

prefLabel

Characteristics of Macular Ede ...... vitreal Bevacizumab Injection.

@en

Characteristics of Macular Ede ...... vitreal Bevacizumab Injection.

@nl

P1433

Q37684328-EC7AE8B3-5233-45D0-A8CA-AE86064641C6

P1476

Q37684328-832EDD84-DE5A-4C12-B122-A8787B26DBAE

P2093

Q37684328-158FBF74-803C-4194-9435-4A9A48EC6870

Q37684328-629BDCED-D947-42B1-A9B4-6EB6A677C558

Q37684328-7A3F57EA-72D6-4F0A-96A8-924939A29CFC

Q37684328-8C5D152A-BC5D-4BAF-AD44-C5FBFB32B82E

Q37684328-A903DBA3-B0C7-4C3C-ADAD-538F7F9EE409

P2860

Q37684328-01FD5B10-6DCD-437F-88DF-5FF6510977DA

Q37684328-03DD3298-AC6A-4CEF-9C04-48D5532E64CE

Q37684328-15FD7786-DE05-4453-BF37-2D50E60CB241

Q37684328-201AE231-14E2-4025-A6B8-A2CF8FA9FEF1

Q37684328-23F1A7AF-6E99-42EA-B3D0-98D0CAA451D2

Q37684328-25100EB0-0BC3-426F-B35F-7B6F913E7B92

Q37684328-279A9A2F-6E52-4A77-8E7C-239377EF8678

Q37684328-40CB8F7E-89CC-4F9A-A425-734D9E80410E

Q37684328-4E45D927-77AA-46EC-B9E9-7A142478FD0F

Q37684328-533AA0E3-E236-457A-B953-B6E0AAD34C68

P304

Q37684328-C61D65BB-558B-4249-BC6A-76CB5516563A

P31

Q37684328-D925DB71-122B-4D97-9921-5EF4DAE8717F

P356

Q37684328-1531A501-A2DC-41C1-BCB4-CD231D619EAD

P433

Q37684328-2568F88A-B81C-4C99-B639-AEC8678292CF

P478

Q37684328-6B8EE0C4-90F4-49B1-A4FD-91B2D09C7EB7

P50

Q37684328-932AFAE0-CF48-435D-ABE7-8F795EB0E625

Q37684328-FBF281D4-FE40-41C5-9E95-7A7294DE8BEF

P577

Q37684328-17BF37EE-D68C-4639-88AA-D46BB0DBCA89

P698

Q37684328-B40903EA-8DDB-4645-ACB6-2120AE799103

P921

Q37684328-31708A2A-CE87-43FF-A444-51A63C046AAC

Q37684328-5527DE48-B98D-4E72-82AD-8A9D1EBA84CF

P932

Q37684328-23114EA5-DCAC-4D25-AF18-66DDE8DDEA05

P356

JOVR.JOVR_254_15

P1433

Journal of Ophthalmic & Vision Research

P1476

Characteristics of Macular Ede ...... vitreal Bevacizumab Injection.

@en

P2093

Farhad Shahram

http://www.w3.org/2001/XMLSchema#string

Fereidoun Davatchi

http://www.w3.org/2001/XMLSchema#string

Hormoz Chams

http://www.w3.org/2001/XMLSchema#string

Mehdi Nilli Ahmadabadi

http://www.w3.org/2001/XMLSchema#string

Sohrab Afshari Mirak

http://www.w3.org/2001/XMLSchema#string

P2860

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.

Mechanisms of fluid accumulation in retinal edema.

The pathogenesis and clinical presentation of macular edema in inflammatory diseases.

Behçet's disease. Report of 41 cases and a review of the literature.

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.

Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease.

Ocular features of Behcet's disease: an international collaborative study

Macular involvement in patients with Behçet's uveitis.

P304

44-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/JOVR.JOVR_254_15

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Fariba Ghassemi

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28299006

http://www.w3.org/2001/XMLSchema#string

P921

Behcet's disease

P932

5340063

http://www.w3.org/2001/XMLSchema#string